Improving Compliance with Medical Treatment Using Eye Drop Aids
Definition
:1. Introduction
2. Data
2.1. Eye Drops: The Challenges
2.2. Possible Solution: Drop Aids
3. Application
3.1. Force Needed to Expel a Drop
3.2. Drop Placement
3.3. Bottle Tip Contact and Contamination Risk
3.4. The Number of Drops Expelled
4. Conclusions and Prospect
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Wakefield, D.; Wildner, G. Is glaucoma an autoimmune disease? Clin. Transl. Immunol. 2020, 9, e1180. [Google Scholar] [CrossRef] [PubMed]
- Tham, Y.C.; Li, X.; Wong, T.Y.; Quigley, H.A.; Aung, T.; Cheng, C.Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Ophthalmology 2014, 121, 2081–2090. [Google Scholar] [CrossRef] [PubMed]
- Mokhles, P.; Schouten, J.S.; Beckers, H.J.; Azuara-Blanco, A.; Tuulonen, A.; Webers, C.A. Glaucoma blindness at the end of life. Acta Ophthalmol. 2017, 95, 10–11. [Google Scholar] [CrossRef] [PubMed]
- Heijl, A.; Leske, M.C.; Bengtsson, B.; Hyman, L.; Bengtsson, B.; Hussein, M.; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch. Ophthalmol. Chic. Ill 1960 2002, 120, 1268–1279. [Google Scholar] [CrossRef] [PubMed]
- Tsai, J.C. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology 2009, 116 (Suppl. 11), S30–S36. [Google Scholar] [CrossRef] [PubMed]
- Buchan, J.; Siddiqui, S.; Gilmour, D. Once daily drop regimes help reduce involuntary non-compliance. Graefes Arch. Clin. Exp. Ophthalmol. Albrecht. Von Graefes Arch. Für. Klin. Exp. Ophthalmol. 2007, 245, 327–328. [Google Scholar] [CrossRef]
- Newman-Casey, P.A.; Salman, M.; Lee, P.P.; Gatwood, J.D. Cost-Utility Analysis of Glaucoma Medication Adherence. Ophthalmology 2020, 127, 589–598. [Google Scholar] [CrossRef]
- Sanchez, F.G.; Mansberger, S.L.; Newman-Casey, P.A. Predicting Adherence with the Glaucoma Treatment Compliance Assessment Tool. J. Glaucoma 2020, 29, 1017–1024. [Google Scholar] [CrossRef]
- Boland, M.V.; Chang, D.S.; Frazier, T.; Plyler, R.; Friedman, D.S. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: The automated dosing reminder study. JAMA Ophthalmol. 2014, 132, 838–844. [Google Scholar] [CrossRef] [Green Version]
- Friedman, D.S.; Okeke, C.O.; Jampel, H.D.; Ying, G.-S.; Plyler, R.J.; Jiang, Y.; Quigley, H.A. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma. Ophthalmology 2009, 116, 1097–1105. [Google Scholar] [CrossRef]
- Broadway, D.C.; Cate, H. Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma. Drugs Aging 2015, 32, 569–581. [Google Scholar] [CrossRef]
- Aleem, A.; Amin, F.; Asim, M.H.; Farooq, N.; Arshad, S.; Raziq, M. Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population. Eur. J. Hosp. Pharm. Sci. Pract. 2021, 28 (Suppl. 2), e191–e196. [Google Scholar] [CrossRef]
- Osman, E.A.; Alqarni, B.A.M.; AlHasani, S.S.H.; Al Harbi, S.S.S.; Gikandi, P.W.; Mousa, A. Compliance of Glaucoma Patients to Ocular Hypotensive Medications Among the Saudi Population. J. Ocul. Pharmacol. Ther. Off J. Assoc. Ocul. Pharmacol. Ther. 2016, 32, 50–54. [Google Scholar] [CrossRef] [PubMed]
- Gurwitz, J.H.; Glynn, R.J.; Monane, M.; Everitt, D.E.; Gilden, D.; Smith, N.; Avorn, J. Treatment for glaucoma: Adherence by the elderly. Am. J. Public Health 1993, 83, 711–716. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Winfield, A.J.; Jessiman, D.; Williams, A.; Esakowitz, L. A study of the causes of non-compliance by patients prescribed eyedrops. Br. J. Ophthalmol. 1990, 74, 477–480. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Konstas, A.G.; Maskaleris, G.; Gratsonidis, S.; Sardelli, C. Compliance and viewpoint of glaucoma patients in Greece. Eye Lond. Engl. 2000, 14 Pt 5, 752–756. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kholdebarin, R.; Campbell, R.J.; Jin, Y.P.; Buys, Y.M. Multicenter study of compliance and drop administration in glaucoma. Can. J. Ophthalmol. 2008, 43, 454–461. [Google Scholar] [CrossRef]
- Davies, I.; Williams, A.M.; Muir, K.W. Aids for eye drop administration. Surv. Ophthalmol. 2017, 62, 332–345. [Google Scholar] [CrossRef]
- Parkkari, M.; Latvala, T.; Ropo, A. Handling Test of Eye Drop Dispenser—Comparison of Unit-Dose Pipettes with Conventional Eye Drop Bottles. J. Ocul. Pharmacol. Ther. 2010, 26, 273–276. [Google Scholar] [CrossRef]
- Connor, A.J.; Severn, P.S. Force requirements in topical medicine use-the squeezability factor. Eye Lond. Engl. 2011, 25, 466–469. [Google Scholar] [CrossRef] [Green Version]
- Wisher, S.J. An assistive eye-drop mold. Am. J. Occup. Ther. Off Publ. Am. Occup. Ther. Assoc. 1991, 45, 751–752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dietlein, T.S.; Jordan, J.F.; Lüke, C.; Schild, A.; Dinslage, S.; Krieglstein, G.K. Self-application of single-use eyedrop containers in an elderly population: Comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol. 2008, 86, 856–859. [Google Scholar] [CrossRef] [PubMed]
- Brand, G.; Hecht, I.; Burgansky-Eliash, Z.; Haim, L.N.B.; Leadbetter, D.; Spierer, O.; Achiron, A. Comparison of the Usability of Eye Drop Aids and the Conventional Bottle. J. Clin. Med. 2021, 10, 5658. [Google Scholar] [CrossRef]
- Davies, I.J.; Brown, N.H.; Wen, J.C.; Stinnett, S.S.; Kubelick, K.; Patel, R.P.; Benokraitis, K.L.; Greene, L.; Cheek, C.; Muir, K.W. An upright eyedrop bottle: Accuracy, usage of excess drops, and contamination compared to a conventional bottle. Clin. Ophthalmol. Auckl. N. Z. 2016, 10, 1411–1417. [Google Scholar] [CrossRef] [Green Version]
- Gomes, B.F.; Lordello, M.; Celli, L.F.; Santhiago, M.R.; Moraes, H.V. Comparison of Eyedrop Instillation Technique with and without a Delivery Device in Inexperienced Patients. Eur. J. Ophthalmol. 2016, 26, 594–597. [Google Scholar] [CrossRef] [PubMed]
- Strungaru, M.H.; Peck, J.; Compeau, E.C.; Trope, G.E.; Buys, Y.M. Mirror-hat device as a drop delivery aid: A pilot study. Can. J. Ophthalmol. 2014, 49, 333–338. [Google Scholar] [CrossRef]
- Averns, H.; Hall, J.; Webley, M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. J. Rheumatol. 1999, 26, 2615–2618. [Google Scholar]
- Zhu, C.Q.; Sadlak, N.; Fiorello, M.G.; Lee, D.; Desai, M. A Comparison of Patient Acceptance of 3 Eye Drop Instillation Aids. J. Glaucoma 2021, 30, 725–731. [Google Scholar] [CrossRef]
- Salyani, A.; Birt, C. Evaluation of an eye drop guide to aid self-administration by patients experienced with topical use of glaucoma medication. Can. J. Ophthalmol. 2005, 40, 170–174. [Google Scholar] [CrossRef]
- Sharma, R.; Singhal, D.; Shashni, A.; Agarwal, E.; Wadhwani, M.; Dada, T. Comparison of Eye Drop Instillation Before and After Use of Drop Application Strips in Glaucoma Patients on Chronic Topical Therapy. J. Glaucoma 2016, 25, e438–e440. [Google Scholar] [CrossRef] [PubMed]
- Goldet, G.; Howick, J. Understanding GRADE: An introduction. J. Evid-Based Med. 2013, 6, 50–54. [Google Scholar] [CrossRef] [PubMed]
- Mathiowetz, V.; Kashman, N.; Volland, G.; Weber, K.; Dowe, M.; Rogers, S. Grip and pinch strength: Normative data for adults. Arch. Phys. Med. Rehabil. 1985, 66, 69–74. [Google Scholar] [PubMed]
- Stone, J.L.; Robin, A.L.; Novack, G.D.; Covert, D.W.; Cagle, G.D. An Objective Evaluation of Eyedrop Instillation in Patients with Glaucoma. Arch. Ophthalmol. 2009, 127, 732–736. [Google Scholar] [CrossRef] [PubMed]
- Alfonso, E.; Kenyon, K.R.; Ormerod, L.D.; Stevens, R.; Wagoner, M.D.; Albert, D.M. Pseudomonas Corneoscleritis. Am. J. Ophthalmol. 1987, 103, 90–98. [Google Scholar] [CrossRef]
- Templeton, W.C.; Eiferman, R.A.; Snyder, J.W.; Melo, J.C.; Raff, M.J. Serratia Keratitis Transmitted by Contaminated Eyedroppers. Am. J. Ophthalmol. 1982, 93, 723–726. [Google Scholar] [CrossRef]
- Solomon, A.; Chowers, I.; Raiskup, F.; Siganos, C.S.; Frucht-Pery, J. Inadvertent conjunctival trauma related to contact with drug container tips: A masquerade syndrome. Ophthalmology 2003, 110, 796–800. [Google Scholar] [CrossRef]
- Gupta, R.; Patil, B.; Shah, B.M.; Bali, S.J.; Mishra, S.K.; Dada, T. Evaluating eye drop instillation technique in glaucoma patients. J. Glaucoma 2012, 21, 189–192. [Google Scholar] [CrossRef]
- Jin, J.; Sklar, G.E.; Min Sen Oh, V.; Chuen Li, S. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther. Clin. Risk Manag. 2008, 4, 269–286. [Google Scholar]
Expected Challenge | Risk Factors for Difficulty |
---|---|
Difficulty in bottle pinching | Lack of physical power, neuropathy |
Difficulty in bottle placement | Tremor, rigidity, poor coordination, fear of corneal touch |
Difficulty in timing | Reduced mental ability, poor memory |
Local side effects | Conjunctival reaction, discomfort, dryness |
Systemic side effects | Compromised pulmonary function, cardiac |
Systemic medication | Confusion about the overall medical treatment regimen |
Publication | Type | No of Patient | Patients | Product | Conclusions | Strength/Quality of Evidence (*) |
---|---|---|---|---|---|---|
Salyami et al. [29] | Prospective, comparative | 93 | POAG patients | Eye drop guide | Aid use lessens compliance | high |
Davies et al. [24] | Prospective, comparative | 40 | POAG patients | Upright eye-drop bottle | No change in placement, fewer drops, less touch | high |
Davies et al. [18] | Meta-analysis | 14 publications 1194 patients | 14 different aids | Better pinch power, better coordination | very high | |
Gomes et al. [25] | Prospective | 23 | naive | Xal-ease | No reduction in drops, less touch and no difference in general use | low |
Strungaru et al. [26] | Prospective, comparative | 30 | POAG | Mirror hat device | No change in time, number of drops and placement. Less touch and better vision of drops | medium |
Averns et al. [27] | Prospective, comparative | 30 | RA patients | Opticare | Better pinch power. Less Fewer drops | medium |
Connor et al. [20] | Comparison of physical properties | none | none | Xal-ease, Opticare, Eyot, Opticare | Increased power is needed in the first three cases, decreased in the last | N/A |
Zhu et al. [28] | Prospective, comparative | 39 | POAG patients | Autodrop, autosqueeze, simplitouch | Fewer drops missed in Autodrop, increased patient satisfaction | low |
Sharma et al. [30] | Prospective, comparative | 72 | POAG patients | Application strips | Less eye contact, fewer drops missed | medium |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Biran, A.; Goldberg, M.; Shemesh, N.; Achiron, A. Improving Compliance with Medical Treatment Using Eye Drop Aids. Encyclopedia 2023, 3, 919-927. https://doi.org/10.3390/encyclopedia3030065
Biran A, Goldberg M, Shemesh N, Achiron A. Improving Compliance with Medical Treatment Using Eye Drop Aids. Encyclopedia. 2023; 3(3):919-927. https://doi.org/10.3390/encyclopedia3030065
Chicago/Turabian StyleBiran, Amit, Mordechai Goldberg, Nadav Shemesh, and Asaf Achiron. 2023. "Improving Compliance with Medical Treatment Using Eye Drop Aids" Encyclopedia 3, no. 3: 919-927. https://doi.org/10.3390/encyclopedia3030065